The Net Margin of Clovis Oncology Inc (CLVS) is
-177.82%.
Net Margin measures the percentage of net income derived from total revenue after all expenses. It signals how much actual profit a company retains from its sales.
| Date |
Value |
| 2021-12-31 |
-177.82%
|
| 2020-12-31 |
-224.44%
|
| 2019-12-31 |
-280.00%
|
| 2018-12-31 |
-385.74%
|
| 2017-12-31 |
-624.14%
|
| 2016-12-31 |
-349100.00%
|
| 2015-12-31 |
-349100.00%
|
| 2014-12-31 |
-1176.47%
|
| 2013-12-31 |
-1176.47%
|
| Ticker |
Name |
Value |
|
AFMD
|
Affimed NV
|
-1280.22%
|
|
DTIL
|
Precision Biosciences, Inc
|
-133.45%
|
|
HARP
|
Harpoon Therapeutics Inc
|
-212.19%
|
|
ACIU
|
AC Immune AG
|
-1971.65%
|
|
MRUS
|
Merus NV
|
-595.02%
|
|
CNTG
|
Centogene NV
|
-73.21%
|
|
ADAP
|
Adaptimmune Therapeutics PLC
|
-39.78%
|
|
IDYA
|
IDEAYA Biosciences, Inc.
|
-51.99%
|
|
RIGL
|
Rigel Pharmaceuticals, Inc.
|
124.72%
|
|
ABBV
|
AbbVie Inc.
|
6.91%
|
|
INBX
|
Inhibrx Biosciences Inc
|
-10773.46%
|
|
KPTI
|
Karyopharm Therapeutics Inc.
|
-134.21%
|
|
VYGR
|
Voyager Therapeutics, Inc.
|
-296.53%
|
|
AMGN
|
Amgen Inc
|
20.98%
|
|
EPZM
|
Epizyme Inc
|
-670.96%
|
|
GILD
|
Gilead Sciences, Inc.
|
28.90%
|
|
GTHX
|
G1 Therapeutics Inc
|
-58.13%
|
|
JNCE
|
Jounce Therapeutics Inc
|
-62.10%
|
|
MTEM
|
Molecular Templates Inc
|
-14.18%
|
|
SYRS
|
Syros Pharmaceuticals Inc
|
-1656.34%
|
|
950160.KQ
|
Kolon TissueGene Inc
|
-3733.25%
|
|
XBIT
|
XBiotech Inc
|
-820.45%
|
|
ANAB
|
AnaptysBio, Inc.
|
246.96%
|
|
KALV
|
KalVista Pharmaceuticals, Inc.
|
-223.16%
|
|
MRNA
|
Moderna, Inc.
|
-145.16%
|
|
AGEN
|
Agenus Inc
|
0.10%
|
|
CMRX
|
Chimerix Inc
|
-41691.98%
|
|
CTMX
|
CytomX Therapeutics, Inc.
|
-22.79%
|
|
DVAX
|
Dynavax Technologies Corp
|
9.85%
|
|
REGN
|
Regeneron Pharmaceuticals, Inc.
|
31.41%
|
|
SGTX
|
Sigilon Therapeutics Inc
|
-336.53%
|
|
SURF
|
Surface Oncology Inc
|
-211.95%
|
|
VRTX
|
Vertex Pharmaceuticals Incorporated
|
32.94%
|
|
950220.KQ
|
Neoimmunetech Inc
|
-33533.01%
|
|
KDNY
|
Chinook Therapeutics Inc
|
-3065.68%
|
|
VNDA
|
Vanda Pharmaceuticals Inc
|
-102.02%
|
|
950200.KQ
|
Psomagen Inc
|
-5.04%
|